Healthcare provider profile · identity verified

Mario Jay Fatigati, MD

Internal Medicine · BRIDGEVILLE, PA · NPI 1083677215

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	786	191
Eliquis	Apixaban	513	69
Amlodipine Besylate	Amlodipine Besylate	458	95
Levothyroxine Sodium	Levothyroxine Sodium	433	88
Gabapentin	Gabapentin	327	52
Tamsulosin Hcl	Tamsulosin Hcl	262	46
Losartan Potassium	Losartan Potassium	261	52
Pantoprazole Sodium	Pantoprazole Sodium	227	73
Carvedilol	Carvedilol	225	39
Furosemide	Furosemide	220	54
Lisinopril	Lisinopril	216	57
Donepezil Hcl	Donepezil Hcl	207	30
Metoprolol Tartrate	Metoprolol Tartrate	200	42
Omeprazole	Omeprazole	200	44
Metformin Hcl	Metformin Hcl	199	48
Escitalopram Oxalate	Escitalopram Oxalate	191	35
Sertraline Hcl	Sertraline Hcl	186	30
Trazodone Hcl	Trazodone Hcl	180	30
Metoprolol Succinate	Metoprolol Succinate	154	36
Potassium Chloride	Potassium Chloride	137	30
Simvastatin	Simvastatin	108	25
Atenolol	Atenolol	105	21
Jardiance	Empagliflozin	105	18
Prednisone	Prednisone	102	39
Memantine Hcl	Memantine Hcl	99	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	98	27
Duloxetine Hcl	Duloxetine Hcl	97	20
Carbidopa-Levodopa	Carbidopa/Levodopa	91	12
Finasteride	Finasteride	85	12
Mirtazapine	Mirtazapine	83	17
Clopidogrel	Clopidogrel Bisulfate	81	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	80	19
Bumetanide	Bumetanide	79	16
Xarelto	Rivaroxaban	78	11
Famotidine	Famotidine	76	17
Hydralazine Hcl	Hydralazine Hcl	75	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	75	18
Irbesartan	Irbesartan	75	25
Spironolactone	Spironolactone	72	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	71	suppressed
Allopurinol	Allopurinol	70	19
Citalopram Hbr	Citalopram Hydrobromide	70	18
Pravastatin Sodium	Pravastatin Sodium	68	suppressed
Buspirone Hcl	Buspirone Hcl	65	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	19
Quetiapine Fumarate	Quetiapine Fumarate	65	17
Fluoxetine Hcl	Fluoxetine Hcl	60	suppressed
Latanoprost	Latanoprost	60	suppressed
Farxiga	Dapagliflozin Propanediol	59	12
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	59	18
Lorazepam	Lorazepam	56	30
Metformin Hcl Er	Metformin Hcl	56	suppressed
Tradjenta	Linagliptin	56	suppressed
Levetiracetam	Levetiracetam	55	suppressed
Alprazolam	Alprazolam	52	16
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	50	suppressed
Amiodarone Hcl	Amiodarone Hcl	49	12
Alendronate Sodium	Alendronate Sodium	48	17
Ozempic	Semaglutide	45	suppressed
Tramadol Hcl	Tramadol Hcl	45	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	suppressed
Baclofen	Baclofen	44	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	41	15
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	41	11
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Breo Ellipta	Fluticasone/Vilanterol	37	suppressed
Clonazepam	Clonazepam	37	11
Meloxicam	Meloxicam	37	suppressed
Raloxifene Hcl	Raloxifene Hcl	37	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	12
Ezetimibe	Ezetimibe	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	32	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Hydrocortisone	Hydrocortisone	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Colestipol Hcl	Colestipol Hcl	29	suppressed
Olanzapine	Olanzapine	29	suppressed
Celecoxib	Celecoxib	28	suppressed
Entresto	Sacubitril/Valsartan	28	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Bethanechol Chloride	Bethanechol Chloride	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Risperidone	Risperidone	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Ondansetron Odt	Ondansetron	23	16
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Albuterol Sulfate	Albuterol Sulfate	22	suppressed
Digoxin	Digoxin	22	suppressed
Divalproex Sodium	Divalproex Sodium	22	suppressed
Topiramate	Topiramate	22	suppressed
Glimepiride	Glimepiride	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Jantoven	Warfarin Sodium	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Risedronate Sodium	Risedronate Sodium	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	16
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	19	19
Cefuroxime	Cefuroxime Axetil	19	13
Diltiazem Hcl	Diltiazem Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Lumigan	Bimatoprost	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Ranolazine Er	Ranolazine	17	suppressed
Admelog	Insulin Lispro	16	suppressed
Amoxicillin	Amoxicillin	16	13
Aripiprazole	Aripiprazole	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	16	suppressed
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Methimazole	Methimazole	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Cephalexin	Cephalexin	15	12
Clonidine Hcl	Clonidine Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Glipizide	Glipizide	14	suppressed
Nystatin	Nystatin	14	suppressed
Piroxicam	Piroxicam	14	suppressed
Timolol Maleate	Timolol Maleate	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Armour Thyroid	Thyroid,pork	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Clonidine	Clonidine	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Xiidra	Lifitegrast	11	suppressed
Zenpep	Lipase/Protease/Amylase	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error